Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupClifford R. Jack, Marı́a C. Carrillo, J. Scott Andrews et al.|Alzheimer s & Dementia|2024Cited by 2.3k
Trial of Solanezumab in Preclinical Alzheimer’s DiseaseReisa A. Sperling, Paul Aisen, Michael Donohue et al.|New England Journal of Medicine|2023Cited by 382
The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's diseaseMichael S. Rafii, Paul Aisen, Reisa A. Sperling et al.|Alzheimer s & Dementia|2022Cited by 266
Revised criteria for the diagnosis and staging of Alzheimer’s diseaseClifford R. Jack, Marı́a C. Carrillo, Scott J. Andrews et al.|Nature Medicine|2024Cited by 165
Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's diseaseRobert A. Rissman, Oliver Langford, Rema Raman et al.|Alzheimer s & Dementia|2023Cited by 147